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A B S T R A C T
Purpose: To study the characteristics, outcomes and prognostic markers of convulsive status epilepticus
(SE) in Singapore.
Methods: 62 adult admissions to the National University Hospital Singapore from 2002 to 2005 were
studied. Ethnicity, history of epilepsy, educational subnormality, neuroimaging, seizure duration, length
of stay, Modiﬁed Rankin Scale (MRS) pre and post discharge, blood glucose, creatine kinase, potassium,
white cell and platelet count were recorded. An MRS  3 at discharge was deﬁned as a poor outcome.
ROCs of signiﬁcant variables were plotted to identify the best test cut-offs.
Results: Mean age was 59.2 years (range 20–94). 75.9% patients had epilepsy. Mean length of stay was 14
days (range 1–75). Univariate analyses revealed age (p = 0.01, OR 1.075, 95% CI 1.030–1.122), length of
stay in ICU (p = 0.03, OR 1.299, 95% CI 1.014–1.665) and hospital (p = 0.014, OR 1.203, 95% CI 1.038–1.393)
and hyperglycemia (p = 0.045, OR 1.327, 95% CI 1.007–1.750) associated with poor outcome. Test cut-off
values for prognostic markers were established: age  55 years (ROC 0.790, sensitivity 72.3, speciﬁcity
85.7, PPV9 4.4%, NPV 48.8%) and serum glucose  7 mmol/L (ROC 0.737, sensitivity 72.3, speciﬁcity 80.0,
PPV 93.5%, NPV 36.4%). A discriminantmodel using these variables was then constructedwith probability
scores for poor outcome.
Discussion: Age, hyperglycemia and length of stay in hospital inﬂuenced outcome from convulsive SE in
the local population with hyperglycemia being a novel prognosticmarker. Some prognosticmarkers cited
in the literature differed, highlighting the possibility that these indicators may vary across population
groups.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Status epilepticus (SE) carries a signiﬁcant mortality, ranging
from7to40%basedonreportspredominantly fromtheUnitedStates
andEurope.1–4ProlongedrefractorySEcancausesevereneurological
morbidity.3 The treatment strategies for SE are not without
potentially life-threatening consequences leading to the inevitable
dilemma as to how aggressively some cases should be managed.2
There has been a lack of data on SE in Singapore hence little is
known of the demographic and clinical features within a
predominantly Asian multi-ethnic population. We previously
reported cases of severe new onset and highly refractory SE with* Corresponding author. Tel.: +65 67724353; fax: +65 67794112.
E-mail address: rahulrathakrishnan@yahoo.com.sg (R. Rathakrishnan).
1059-1311/$ – see front matter  2008 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2008.09.005dismal outcomes.5 These cases were fortunately a rare occurrence
but prompted us to examine all cases of SE admitted to our tertiary
institution. Emerging literature has highlighted certain clinical
features that identify patients with poor prognoses in the early
stages of presentation that may guidemanagement plans.2,3,6,7 We
aimed to identify prognostic features within our local population
and compared these to other reports.
2. Materials and methods
This was a retrospective case-note study. Admissions to the
National University Hospital, a tertiary referral center between
January 2002 and December 2005 were examined. Patients were
identiﬁed using an electronic hospital database. Patients dis-
charged in the index period with an International Classiﬁcation of
Diseases (ICD)-9 code concerning epilepsy (345. X and allvier Ltd. All rights reserved.
Table 1
Demographic features of patients included in the study.
Number of patients (%)
Male 34 (58.6)
Ethnicity–Chinese 36 (62.1)
Malay 11 (19)
Indian 6 (10.3)
Others 5 (8.6)
Known epilepsy (from any etiology) prior to admission 44 (75.9)
Educationally subnormal 6 (10.3)
Mortality 7 (12.1)
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discharge diagnosis were evaluated. Case-notes were individually
reviewed. Adults over the age of 18 years were included. We
excluded children because the differing causes and prognoses of SE
in this population indicate that this is a largely heterogeneous
group.8,9 SE was deﬁned as ongoing seizures and/or repetitive
seizures without intercurrent normalization of consciousness or
return to baseline for at least 30 min. Only patients who presented
with convulsive (deﬁned as witnessed generalized motor mani-
festations, within or outside hospital) SE were included since the
time of onset and seizure duration could be more accurately
determined. Patients with a non-convulsive, partial SE, ‘subtle’ SE
and SE secondary to post-anoxic encephalopathy were excluded.
We recorded age, gender, ethnicity, past history of epilepsy,
educational sub normality (deﬁned as incomplete primary school
education as a direct consequence of mental disability), structural
abnormality on neuroimaging, concurrent anticonvulsant regime,
length of stay in the intensive care/high-dependency unit and
etiology of the SE. Following careful review of the case-notes,
etiology was grouped into several headings according to interna-
tional recommendations8:(1) Acute (provoked) symptomatic.
(2) Remote (unprovoked) symptomatic.
(3) Progressive (unprovoked) neurologic conditions.
(4) Cryptogenic.
White cell count, platelet count, serum potassium, creatine kinase
and glucose at the time of presentation were recorded. A leukocytosis
is often seen post-ictally.9 Rhabdomyolsis (along with the hyperka-
lemia associated with it) and disruption in glucose homeostasis is
recognized in convulsive status epilepticus.10–12 We found that the
above laboratory data were recorded in all SE patients at the time of
presentation and hence we were curious if any were potential
prognostic markers.
The Modiﬁed Rankin Scale (MRS)15 was used as a functional
outcome measure and an MRS score was given prior to admission
(based on information from relatives and carers) and at the point of
discharge.
The MRS scoring system is shown below:0 No symptoms1 No signiﬁcant disability despite symptoms; able to
carry out all
usual duties and activities2 Slight disability; unable to carry out all previous activities,
but able to look after own affairs without assistance3Table 2Moderate disability; requiring some help but able to walk
without assistanceDistribution of etiology of SE in order of frequency.4Etiology of status epilepticus Post-MRS  2 Post-MRS  3 TotalModerately severe disability; unable to walk without
assistance and unable to attend to own bodily needs
without assistanceAcute 2 7 9
Remote 7 30 375Cryptogenic 3 3 6Severe disability, bedridden, incontinent and requiring
constant nursing care and attentionProgressive 2 7 96 DeadTable 3
Modiﬁed Rankin Scale (MRS) pre-admission (Pre-MRS) and at the time of discharge
(Post-MRS) categorized with a cut-off of 3.
Modiﬁed Rankin
Scale
Pre-MRS
(number of cases)
Post-MRS
(number of cases)
2 29 14
3 32 472.1. Statistical analysis
Data was collected and statistical calculations were performed
using SPSS v11.0. Frequency distributions of potential predictive
features were studied.We deﬁned patients with anMRS at the time
of discharge of 3 as having a poor outcome. The association of
individual factors with a poor outcome was analysed using the
Fisher exact test. The receiver operating characteristic curves (ROCs)were performed on the signiﬁcant variables from the univariate
analysis to obtain the best test cut-off value that identiﬁed patients
with a poor outcome. Using these predetermined cut-offs, the
multivariate logistic regressionwas applied to create a discriminant
model with probability scores for poor outcome.
3. Results
A total of 61 admissions of 58 patients were included. Mean age
of the patients was 58.4 years (standard deviation 18.5, range 20–
94 years). Demographic data is presented in Table 1.
The mean duration of seizures using clinical correlation
(deﬁned as cessation of convulsive motor activity) prior to
termination of SE was 98.7 min (30–540). 50 (82%) cases had
clinical evidence of ongoing seizures upon arrival in the Emergency
Department. Mean length of stay in the intensive care or high-
dependency settingwas 5 days (range 0–55 days) and hospital was
14 days (range 0–75 days).
43 (74.1%) patients underwent neuroimaging of which 24.1%
had MRI scans. Structural brain abnormalities were detected in
93% of these patients. 37 cases (60%) underwent EEG during the
admission with a median time to EEG of 24 h.
In 42 cases (68.9%), patients were on anticonvulsants prior to
SE. Etiology of the SE is displayed in Table 2. Univariate analysis
revealed etiology had no signiﬁcant effect on outcome in our
study (p = 0.419). Table 3 displays the Modiﬁed Rankin Scale
(MRS) pre-admission (Pre-MRS) and at the time of discharge
(Post-MRS).
Using our deﬁnition of poor outcome as those patients who had
a MRS at the time of discharge of3, 18 (29.5%) cases deteriorated
in functional status. Univariate analyses of the demographic,
clinical and laboratory features were performed (Table 4). Multi
variate analysis and ROC curves of the signiﬁcant variables that
Table 5
Multivariate analysis of the signiﬁcant variables that might be applied as early
indicators of poor outcome.
p value Odds ratio
(95% conﬁdence interval)
Age 0.020 1.097 (1.015–1.185)
Glucose 0.047 1.551 (1.003–2.394)
Table 7
Probability scores of poor outcome in patients with the above characteristics at the
time of presentation.
Glucose  7 Age  55 Probability of Post- MRS  3
No No 0.2385
No Yes 0.6182
Yes No 0.6182
Yes Yes 0.8933
Table 4
Univariate analysis of demographical, clinical and laboratory data in patients with a
poor outcome.
p value Odds ratio (95%
conﬁdence interval)
Age 0.01 1.075 (1.030–1.122)
Males 0.871 1.105 (0.330–3.70)
Chinese 0.203 2.488 (0.612–10.122)
Educational disability 0.529 0.558 (0.091–3.424)
Known epilepsy 0.387 0.486 (0.095–2.492)
Seizure duration(>60minutes) 0.262 1.009 (0.994–1.024)
Structural abnormality 0.251 4.625 (0.339–63.06)
LOS ICU 0.03 1.299(1.014–1.665)
LOS hospital 0.014 1.203 (1.038–1.393)
Glucose 0.045 1.327 (1.007–1.750)
Creatine kinase 0.508 1.000 (0.998–1.007)
Potassium 0.145 1.904 (0.800–4.530)
White cell count 0.208 1.103 (0.947–1.284)
Platelet count 0.190 1.004 (0.998–1.011)
Values in bold indicate variables with p value <0.05.
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performed (Tables 5 and 6).
Applying these to a discriminant model, probability scores
ranging from 0 to 1were calculated. A value closer to one indicated
a higher probability of a poor outcome. As all patients with a Pre-
MRS  3 remained with Post-MRS of  3, this variable was
excluded from the model (Table 7). ROC of the constructed model
was 0.817.
4. Discussion
We aimed to study SE in the Singapore population to answer
these questions:- AT
S
G
Are the clinical and demographic features similar to other reports
in the international literature?- Are there clinically useful prognostic markers?
In this study, gender and ethnicity of patientswere not signiﬁcant risk
factors for the development of SE and did not inﬂuence the prognosis.
The ethnic distribution of the study populationwas comparable to the
composition of the population nationally and emphasizes the
advantage of population studies in a multi-ethnic society such as
that in Singapore.
In keeping with international reports, increasing age was
signiﬁcantly associated with poor functional outcome and higher
mortality.1,2,6,7,13,16 In addition, length of stay in the intensive care
unit and hyperglycemia on arrival correlated with poorer
prognoses. Elderly patients are more likely to spend a longer
period in an intensive care setting although this may be due to the
complications rather than a direct result of the SE per se. In anable 6
tatistical analysis on the potential use of early prognostic markers.
ROC Sensitivity Speciﬁcity
lucose  7 0.737 72.3 80.0
ge  55 0.790 72.3 85.7aging population, the data of epidemiological studies may be
signiﬁcantly biased by age and the time may come when elderly
patients are categorized separately as a distinct subgroup.
The relationship between hyperglycemia and poor outcome
has to our knowledge never been established in the literature. It
is uncertain if this is a feature that may be unique to the Singapore
population. The high catecholamine drive that is recognized in
the early stages of SE pathophysiologically causes hyperglyce-
mia.14,20 In vitro studies conﬁrm that hyperglycemia increases
hippocampal neuronal excitability, propagating status epilepti-
cus.17 The neuronal toxicity of hyperglycemia is well established in
the cerebrovascular disease model, accounting for increased
mortality and poorer outcomes.18 We postulate that the degree
of serologically measurable hyperglycemia may be a reﬂection of
these mechanisms at work and have a direct bearing on the poorer
prognoses seen in such cases.
This study conﬁrms that an established diagnosis of epilepsy is a
risk factor for SE but is not associated with poor outcome.7,14,19
Etiology has been cited as a signiﬁcant predictor of outcome.16,21 In
our study, etiology did not appear to signiﬁcantly affect outcome.
The majority of the patients had a remote etiology indicating
established central nervous system lesions.8 The outcomewas poor
in the majority (77.8%) of patients who had an acute symptomatic
etiology, consistent with other reports.3,6 Etiology was not formally
studied when we were assessing potential prognostic markers as it
would have been difﬁcult to determine etiology at an early enough
stage inmost cases for this to beuseful. In our study, the etiology did
not signiﬁcantly predict outcome for several likely reasons: we
employed the MRS score as a marker of outcome rather than
mortality and included cases of convulsive SE only.
The high number of patients with underlying educational sub
normality (all of whom had pre-existing epilepsy) represents a
group of patients with underlying abnormal CNS function which is
a predisposing factor in epileptogenesis.21,22 A link between
epilepsy and learning disability has been established yet it remains
unclear whether mental disability represents an independent risk
factor for the development of SE.22 There was no evidence that this
was a signiﬁcant prognostic indicator in our study. It ought to
however be noted that this cohort of patients does not include
thosewho died as a result of SUDEP, a signiﬁcant cause ofmortality
in learning disabled patients with epilepsy.21
The duration of seizures was not a reliable prognostic marker in
our study. The literature has been inconsistent regarding this
matter due to difﬁculty in establishing the deﬁnite effect of seizure
duration independent of etiology.4,16,19 Determination of the time
of onset and abolition can be difﬁcult. It is now well recognized
that a number of patients continue to have electrographical
evidence of seizures with no clear motor manifestations.7,14
However establishing an accurate duration of SE electrographicallyPositive predictive value (PPV) (%) Negative predictive value (NPV) (%)
93.5 36.4
94.4 48.8
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achieve. To ensure uniformity in our clinical data, we deﬁned the
onset of convulsive SE as the time at which generalized motor
manifestations began and termination as cessation of all motor
activity of the limbs. Thewide variation in the seizure durationwas
largely due to the delay in patients being brought to hospital,
which also accounts for the high percentage of patients that were
having on-going seizures upon arrival in the Emergency Depart-
ment. Singapore has an extensive paramedical service with rapid
response times and it is likely that a delay in the activation of
emergency medical services was the cause although we were
unable to determine this objectively. There remains a signiﬁcant
social stigma attached to the diagnosis of epilepsy with poor levels
of patient education which needs to be addressed.23 The high
proportion of cases (75.9%) known to have epilepsy prior to the
admission with SE would lend support to this. Furthermore, this
ﬁgure is likely an underestimate as it was dependent on self-
reporting.
The next phase of the study involved the application of the
relevant demographic and clinical features that were signiﬁcantly
associatedwith a poor outcome into a predictivemodel. All patients
who had a poor pre-morbid functional status prior to presentation
were discharged in an equally poor if not worse state and this is not
surprising when we consider the signiﬁcant morbidity associated
with convulsive SE. Indicators of prognosis at the time of
presentation such as age and serum glucose were statistically
applied in the group of patients with anMRS of3. The high ROC of
this discriminantmodel indicates its potential use as a predictor.We
found that patients with normal or only mildly impaired functional
status who are above the age of 55 years and are hyperglycemic at
presentation have a signiﬁcant probability of a poor outcome.
5. Conclusion
This study highlights similarities and differences with other
reports on the epidemiological features of SE. In our Singaporean
population we identiﬁed hyperglycemia as a novel prognostic
marker and used in conjunction with age, may provide us with
useful prognostic information at the time of presentation. This
study also emphasizes the possibility of different populations
showing different identiﬁers of poorer prognoses.
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